Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation

Journal of Liposome Research

Volumn 20, Issue 3, 2010, Pages 228-243

  Jaafar Maalej, Chiraz ^a   Diab, Roudayna ^a   Andrieu, Véronique ^b   Elaissari, Abdelhamid ^a   Fessi, Hatem ^a  

^a UNIVERSITÉ LYON 1   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Beclomethasone dipropionate; Cytarabine; Ethanol injection method; Liposomes; Nanoprecipitation; Nebulization; Pulmonary

Indexed keywords

ALCOHOL; BECLOMETASONE DIPROPIONATE; CHOLESTEROL; CYTARABINE; LIPOSOME; PHOSPHOLIPID;

ARTICLE; CANCER CELL CULTURE; CYTOPLASM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

BECLOMETHASONE; CHOLESTEROL; CYTARABINE; DRUG CARRIERS; DRUG STABILITY; HUMANS; LIPOSOMES; LUNG; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHOLIPIDS; SOLVENTS; TUMOR CELLS, CULTURED;

EID: 77955066249     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100903347923     Document Type: Article

References (69)

1. Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Difusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
2. Bard, D. R., Knight, C. G., Page-Tomas, D. P. (1982). Toxicity of liposomal N-acyl daunorubicins to L929 cells in culture. Br J Cancer 45:783-785.
3. Barenholz, Y. (2003). Relevancy of drug loading to liposomal formulation therapeutic efcacy. J Liposome Res 13:1-8.
4. Batzri, S., Korn, E. D. (1973). Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298:1015-1019.
5. Betageri, G. V., Parsons, D. L. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 81:235-241.
6. Bridges, P. A., Taylor, K. M. (2000). An investigation of some of the factors infuencing the jet nebulisation of liposomes. Int J Pharm 204:69-79.
7. Budai, M., Szógyi, M. (2001). Liposomes as drug carrier systems. Preparation, classifcation, and therapeutic advantages of liposomes. Acta Pharm Hung 71:114-118.
8. Campbell, M. J. (1995). Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 18:1027-1032.
9. Carneiro, A., Santana, M. (2004). Production of liposomes in a mul-titubular system useful for scaling up of processes. Progr Coll Polym Sci 128:273-277.
10. Darwis, Y., Kellaway, I. W. (2001). Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int J Pharm 215:113-121.
11. Dass, C. R., Walker, T. L., Burton, M. A. (2002). Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efciency. Drug Deliv 9:11-18.
12. Desai, T. R., Hancock, R. E. W., Finlay, W. H. (2002). A facile method of delivery of liposomes by nebulization. J Contr Rel 84:69-78.
13. Diab, R., Degobert, G., Hamoudeh, M., Dumontet, C., Fessi, H. (2007). Nucleoside analogue delivery systems in cancer therapy. Exp Opin Drug Deliv 4:513-531.
14. Domazou, A., Luisi, P. (2002). Size distribution of spontaneously formed liposomes by the alcohol injection method. J Liposome Res 12:205-220.
15. Epstein, H., Gutman, D., Cohen-Sela, E., Haber, E., Elmalak, O., Koroukhov, N., et al. (2008). Preparation of alendronate lipo-somes for enhanced stability and bioactivity: in vitro and in vivo characterization. AAPS J 10:505-515.
16. Fang, J. Y., Hong, C. T., Chiu, W. T., Wang, Y. Y. (2001). Effect of lipo-somes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61-72.
17. Fessi, H., Puissieux, F., Devissaguet, J., Ties, C. (1988). Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent no.: 5118528.
18. Gregoriadis, G., Davis, C. (1979). Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Bioph Res Co 89: 1287-1293.
19. Gulati, M., Grover, M., Singh, S., Singh, M. (1998). Lipophilic drug derivatives in liposomes. Int J Pharm 165:129-168.
20. Gómez, C., Blanco, M. D., Bernardo, M. V., Olmo, R., Muñiz, E., Theijón, J. M. (2004). Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) flm: in vitro and in vivo studies. Eur J Pharm Biopharm 57:225-233.
21. Güven, A., Ortiz, M., Constanti, M., O'Sullivan, C. K. (2009). Rapid and efcient method for the size separation of homogeneous fuorescein- encapsulating liposomes. J Liposome Res 19: 148-154.
22. Hitzman, C. J., Elmquist, W. F., Wattenberg, L. W., Wiedmann, T. S. (2006). Development of a respirable, sustained release micro-carrier for 5-fuorouracil I: in vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci 95:1114-1126.
23. Hunt, C. A., Rustum, Y. M., Mayhew, E., Papahadjopoulos, D. (1979). Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of diferent size. Drug Metab Dispos 7:124-128.
24. Isele, U., van Hoogevest, P., Hilfker, R., Capraro, H. G., Schieweck, K., Leuenberger, H. (1994). Large-scale production of liposomes containing monomeric zinc phthalocya-nine by controlled dilution of organic solvents. J Pharm Sci 83: 1608-1616.
25. Jaafar-Maalej, C., Andrieu, V., Elaissari, A., Fessi, H. (2009). Assessment methods of inhaled aerosols: technical aspects and applications. Exp Opin Drug Deliv [Epub ahead of print].
26. Juliano, R. L., MucCullough, H. N. (1980). Controlled deivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system. J Pharmacol Exp Ther 214:381-387.
27. Juliano, R. L., Stamp, D., McCullogh, N. (1978). Pharmacokinetics of liposomes encapsulated antitumor drugs and implications for therapy. Ann N Y Acad Sci 308:411-423.
28. Justo, O. R., Moraes, A. M. (2005). Kanamycin incorporation in lipid vesicles prepared by ethanol injection designed for tuberculosis treatment. J Pharm Pharmacol 57:23-30.
29. Karathanasis, E., Ayyagari, A. L., Bhavane, R., Bellamkonda, R. V., Annapragada, A. V. (2005). Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Contr Rel 103:159-175.
30. Kesisoglou, F., Zhou, S. Y., Niemiec, S., Lee, J. W., Zimmermann, E. M., Fleisher, D. (2005). Liposomal formulations of infammatory bowel disease drugs: local versus systemic drug delivery in a rat model. Pharm Res 22:1320-1330.
31. Kikuchi, H., Yamauchi, H. (1987). Method for producing liposomes. US Patent no.: 4687661.
32. Kirby, C. J., Gregoriadis, G. (1984). Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul 1:33-45.
33. Knoll, G., Burger, K. N., Bron, R., van Meer, G., Verkleij, A. J. (1988). Fusion of liposomes with the plasma membrane of epithelial cells: fate of incorporated lipids as followed by freeze fracture and autoradiography of plastic sections. J Cell Biol 107: 2511-2521.
34. Kremer, J. M., Esker, M. W., Pathmamanoharan, C., Wiersema, P. H. (1977). Vesicles of variable diameter prepared by a modifed injection method. Biochemistry 16:3932-3935.
35. Kulkarni, S. B., Betageri, G. V., Singh, M. (1995). Factors afecting microencapsulation of drugs in liposomes. J Microencapsul 12:229-246.
36. Lasic, D. D. (1988). The mechanism of vesicle formation. Biochem J 256:1-11.
37. Liu, D. Z., Chen, W. Y., Tasi, L. M., Yang, S. P. (2000). Micro-calorimetric and shear studies on the efects of cholesterol on the physical stability of lipid vesicles. Coll Surf A 172:57-67.
38. Lopez-Pinto, J. M., Gonzalez-Rodriguez, M. L., Rabasco, A. M. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1-12.
39. Maitani, Y., Soeda, H., Junping, W., Takayama, K. (2001). Modifed ethanol injection method for liposomes containing beta-sitosterol beta-d-glucoside. J Liposome Res 11:115-125
40. Majoral, C., Le Pape A., Diot, P., Vecellio, L., (2006). Comparaison of various methods for processing cascade impactor data. Aerosol Sci Thech 40:672-682.
41. Massing, U., Fuxius, S. (2000). Liposomal formulations of anti-cancer drugs: selectivity and efectiveness. Drug Res Update 3:171-177.
42. Mayhew, E., Rustum, Y. M., Szoka, F., Papahadjopoulos, D. (1979). Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat Rep 63:1923-1928.
43. McCullough, H. N., Juliano, R. L. (1979). Organ-selective action of an antitumor drug: pharmacologic studies of liposomes-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat. J Natl Cancer Inst 63: 727-731.
44. Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., Perrie, Y. (2004). Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285:23-34.
45. Naef, R. (1996). Feasibility of topical liposome drugs produced on an industrial scale. Adv Drug Deliv Rev 18:343-347.
46. Patel, K. R., Baldeschwieler, J. D. (1984). Treatment of intravenously implanted Lewis lung carcinoma with liposome-encapsulated cytosine arabinoside and nonspecifc immunotherapy. J Int Cancer 34:415-420.
47. Pons, M., Foradada, M., Estelrich, J. (1993). Liposomes obtained by the ethanol injection method. Int J Pharm 95:51-56.
48. Rustum, Y. M., Dave, C., Mayhew, E., Papahadjopoulos, D. (1979). Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabino-furanosylcytosine against mouse L1210 leukemia. Cancer Res 39:1390-1395.
49. 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma. Chest 113:1573-1579.
50. Schipper, N. G., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., Artursson, P. (1997). Chitosans as absorption enhancers for poorly absorbable drugs. 2: mechanism of absorption enhancement. Pharm Res 14:923-929.
51. Schubert, M. A., Müller-Goymann, C. C. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles\evaluation of the method and process parameters. Eur J Pharm Biopharm 55:125-131.
52. Sebti, T., Amighi, K. (2006). Preparation and in vitro evaluation of lipidic carriers and fllers for inhalation. Eur J Pharm Biopharm 63:51-58.
53. Sezer, A. D., Akbu?a, J., Ba?, A. L. (2007). In vitro evaluation of enrofoxacin-loaded MLV liposomes. Drug Deliv 14:47-53.
54. Sonar, S., D'Souza, S. E., Mishra, K. P. (2008). A simple one-step protocol for preparing small-sized doxorubicin-loaded lipo-somes. J Environ Pathol Tox 27:181-189.
55. Stano, P., Bufali, S., Pisano, C., Bucci, F., Barbarino, M., Santaniello, M., et al. (2004). Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method. J Liposome Res 14:87-109.
56. Suarez, S., Hickey, A. J. (2000). Drug properties afecting aerosol behavior. Respir Care 45:652-666.
57. Sze, A., Erickson, D., Ren, L., Li, D. (2003). Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic fow. J Coll Interf Sci 261:402-410.
58. Szoka, F. J., Papahadjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USAm 75:4194-4198.
59. Tomoko, N., Fumiyoshi, I. (2005). Encapsulation efciency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198-205.
60. Vemuri, S., Yu, C. D., Wangsatorntanakun, V., Roosdorp, N. (1990). Large-scale production of liposomes by a microfuidizer. Drug Dev Ind Pharm 16:2243-2256.
61. Vidgren, M., Silvasti, M., Korhonen, P., Kinkelin, A., Frischer, B., Stern, K. (1995). Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating efects of salbutamol. Arzneimittel-Forschung 45:44-47.
62. Wagner, A., Vorauer-Uhl, K., Katinger, H. (2002). Liposomes produced in a pilot scale: production, purifcation, and efciency aspects. Eur J Pharm Biopharm 54:213-219.
63. Waldrep, J. C., Gilbert, B. E., Knight, C. M., Black, M. B., Scherer, P. W., Knight, V., et al. (1997). Pulmonary delivery of beclomethasone liposome aerosol in volunteers: tolerance and safety. Chest 111:316-323. (Pubitemid 27096944)
64. Waldrep, J. C., Keyhani, K., Black, M., Knight, V. (1994). Operating characteristics of 18 diferent continuous-fow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 105:106-110.
65. Xu, P., Gullotti, E., Tong, L., Highley, C. B., Errabelli, D. R., Hasan, T., et al. (2009). Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharmaceut 6:190-201.
66. Yan, E. C., Eisenthal, K. B. (2000). Effect of cholesterol on molecular transport of organic cations across liposome bilayers probed by second harmonic generation. Biophys J 79:898-903.
67. Yang, X., Zhao, X., Phelps, M. A., Piao, L., Rozewski, D. M., Liu, Q., et al. (2009). A novel liposomal formulation of favopiridol. Int J Pharm 365:170-174.
68. Zaru, M., Mourtas, S., Klepetsanis, P., Fadda, A. M., Antimisiaris, S. G. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67:655-666.
69. Zhang, Y. L., Frangos, J. A., Chachisvilis, M. (2006). Laurdan fuores-cence senses mechanical strain in the lipid bilayer membrane. Biochem Biophys Res Commun 347:838-841.